Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Kumiko Yahikozawa"'
Autor:
Sho Suzuki, Hirohiko Motoki, Yusuke Kanzaki, Takuya Maruyama, Naoto Hashizume, Ayako Kozuka, Kumiko Yahikozawa, Koichiro Kuwahara
Publikováno v:
ESC Heart Failure, Vol 7, Iss 5, Pp 2752-2761 (2020)
Abstract Aims This study aims to investigate the prognostic impact of mineralocorticoid receptor antagonists (MRAs) on cardiovascular events in patients hospitalized for acute decompensated heart failure with preserved ejection fraction (HFpEF; defin
Externí odkaz:
https://doaj.org/article/c96d321599ff4eb5b4fc52b835e3e780
Autor:
Sho Suzuki, Naoto Hashizume, Yusuke Kanzaki, Takuya Maruyama, Ayako Kozuka, Kumiko Yahikozawa
Publikováno v:
PLoS ONE, Vol 14, Iss 7, p e0219044 (2019)
BACKGROUND:Stable coronary artery disease (CAD) is known to have an increased risk of cardiovascular events. Serum albumin (Alb) is reported as a useful risk-stratification tool in cardiovascular diseases such as acute coronary syndrome or heart fail
Externí odkaz:
https://doaj.org/article/f5d90a8ca5b943728dc4824e89d7358d
Autor:
Naoto Hashizume, Yusuke Kanzaki, Sho Suzuki, Ayako Okada, Kumiko Yahikozawa, Hirohiko Motoki, Tatsuya Saigusa, Soichiro Ebisawa, Takuya Maruyama, Ayako Kozuka, Koichiro Kuwahara, Fumika Nomoto
Publikováno v:
Journal of Cardiology Cases
The incidence of Dressler’s syndrome after myocardial infarction (MI) has decreased in the reperfusion therapy era. Although guidelines recommend high-dose aspirin for treatment based on evidence from the pre-percutaneous coronary intervention (pre
Autor:
Yusuke Kanzaki, Naoto Hashizume, Takuya Maruyama, Koichiro Kuwahara, Kumiko Yahikozawa, Hirohiko Motoki, Sho Suzuki, Ayako Kozuka
Publikováno v:
ESC Heart Failure, Vol 7, Iss 5, Pp 2752-2761 (2020)
Aims This study aims to investigate the prognostic impact of mineralocorticoid receptor antagonists (MRAs) on cardiovascular events in patients hospitalized for acute decompensated heart failure with preserved ejection fraction (HFpEF; defined as lef
Autor:
Naoto Hashizume, Hirohiko Motoki, Sho Suzuki, Koichiro Kuwahara, Yusuke Kanzaki, Takuya Maruyama, Kumiko Yahikozawa, Ayako Kozuka
Publikováno v:
International Heart Journal. 61:325-331
Prediction of short-term mortality in elderly patients with heart failure (HF) would be useful for clinicians when discussing HF management or palliative care.A prospective multicenter cohort study was conducted between July 2014 and July 2018. A tot
Autor:
Sho Suzuki, Ayako Kozuka, Naoto Hashizume, Takuya Maruyama, Koichiro Kuwahara, Kumiko Yahikozawa, Hirohiko Motoki, Yusuke Kanzaki
Publikováno v:
Heart and Vessels. 35:1109-1115
The prognostic significance of resting heart rate (HR) in atrial fibrillation (AF) patients with heart failure with reduced ejection fraction (HFrEF) is unclear, and there are no recommendations about the optimal HR in patients with HF in the current
Autor:
Yusuke Kanzaki, Hirohiko Motoki, Sho Suzuki, Takuya Maruyama, Kumiko Yahikozawa, Ayako Kozuka, Koichiro Kuwahara, Naoto Hashizume
Publikováno v:
Circulation Reports
Background: Clinical evidence of the effects of loop diuretics in patients with heart failure with preserved ejection fraction (HFpEF) is lacking. Thus, we compared the impact of azosemide and furosemide, long- and short-acting loop diuretics, in pat
Autor:
Kumiko Yahikozawa, Takuya Maruyama, Ayako Kozuka, Sho Suzuki, Naoto Hashizume, Yusuke Kanzaki, Hirohiko Motoki, Koichiro Kuwahara, Aya Fuchida
Publikováno v:
Heart and Vessels
Although systolic blood pressure (SBP) is routinely considered when treating acute heart failure (HF), diastolic blood pressure (DBP) is hardly been assessed in the situation. There are no previous studies regarding the predictive value of DBP in eld
Autor:
Kumiko Yahikozawa, Naoto Hashizume, Sho Suzuki, Yusuke Kanzaki, Takuya Maruyama, Ayako Kozuka
Publikováno v:
PLoS ONE, Vol 14, Iss 7, p e0219044 (2019)
PLoS ONE
PLoS ONE
Background Stable coronary artery disease (CAD) is known to have an increased risk of cardiovascular events. Serum albumin (Alb) is reported as a useful risk-stratification tool in cardiovascular diseases such as acute coronary syndrome or heart fail
Publikováno v:
International Heart Journal. 48:423-433
Background: Previous studies have shown that intracoronary nitroprusside injection is safe and effective after slow reflow complicates percutaneous coronary intervention (PCI). Objectives: We sought to determine the safety and efficacy of selective i